1 |
Hamdiye CT, Yavuz G, Kamil T, Mine S: Anesthesiamanagement of a child with adrenoleukodystrophy. Paediatr Anaesth 2006; 16(2): 221-2.
DOI
ScienceOn
|
2 |
van Geel BM, Assies J, Haverkort EB, Koelman JH, Verbeeten B, Jr., Wanders RJ, et al. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil". J Neurol Neurosurg Psychiatry 1999; 67(3): 290-9.
DOI
|
3 |
Moser H, Dubey P, Fatemi A: Progress in X-linked adrenoleukodystrophy. Curr Opin Neurol 2004a; 17(3): 263-9.
DOI
ScienceOn
|
4 |
Moser HW, Fatemi A, Zackowski K, Smith S, Golay X, Muenz L, et al. Evaluation of therapy of X-linked adrenoleukodystrophy. Neurochem Res 2004b; 29(5): 1003-16.
DOI
|
5 |
Rizzo WB, Leshner RT, Odone A, Dammann AL, Craft DA, Jensen ME, et al. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 1989; 39(11): 1415-22.
DOI
|
6 |
Schwartz RE, Stayer SA, Pasquariello CA, Lowe DA, Foster CJ. Anaesthesia for the patient with neonatal adrenoleukodystrophy. Can J Anaesth 1994; 41(1): 56-8.
DOI
ScienceOn
|
7 |
Kindopp AS, Ashbury T: Anaesthetic management of an adult patient with X-linked adrenoleukodystrophy. Can J Anaesth 1998; 45(10): 990-2.
DOI
ScienceOn
|
8 |
Krivit W, Peters C, Shapiro EG: Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12(2): 167-76.
DOI
ScienceOn
|
9 |
Dobson G, Lyons J: Anaesthesia for a life-limited child with adrenoleucodystrophy. Eur J Anaesthesiol 2004; 21(1): 78-9.
|